Datroway (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...

Myricx Bio, a UK biotech focusing on the discovery and development of a novel class of payloads for antibody-drug conjugates ...

Ireland’s government remains confident in its ability to retain the country’s strategic position in pharmaceutical ...

Following hot on the heels of Monday’s European Commission EC approval of an indication extension for Johnson & Johnson’s ...

US biotech company Vertex Pharmaceuticals (Nasdaq: VRTX) has received European Commission approval to extend the use of its ...

The USA’s Centers for Medicare & Medicaid Services (CMS) yesterday released the Calendar Year (CY) 2026 Rate Announcement for ...

Australia’s Therapeutics Goods Administration (TGA) has issued a safety notice on isotretinoin, originally sold as Roaccutane ...

US biotech start-up RayThera has secured $110 million in series A financing to fund the early clinical development of its ...

The UK’s Prime Minister has announced action to accelerate the discovery of life-saving drugs, improve patient care and make ...

US biopharma Rhythm Pharmaceuticals has announced positive topline results from the pivotal Phase III TRANSCEND trial evaluating setmelanotide, a melanocortin-4 receptor (MC4R) agonist, for the ...

At the recent AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Disease (PD), Cerevance announced that solengepras, a first-in-class G-protein coupled receptor 6 (GPR6) antagonist in ...

Alzheon, a privately-held clinical-stage biopharma company, presented promising Phase III APOLLOE4 trial results for ALZ-801 ...